Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02567968 · ClinicalTrials.gov registry record · Phase 4

A Study to Determine if Caffeine Accelerates Emergence From Anesthesia

A Phase 4 study, sponsored by University of Chicago.

Completed
Registry status
Phase 4
Development phase
8
Enrollment target

NCT02567968 is a Phase 4 study that has completed, run by University of Chicago. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02567968, a Phase 4 study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
Phase 4
Development phase
8 participants
Enrollment target

Study Summary

At present clinicians have no way to reverse anesthesia. Patients wake when their bodies clear the anesthetic. Most people wake quickly, but some do not. All patients have memory and other cognitive problems after waking from anesthesia. In studies on animals, the investigators observed that caffeine caused rats and mice to wake much more rapidly from anesthesia. This was true for all the animals tested. The investigators would like to see if this holds true in humans. Will caffeine accelerate waking from anesthesia? Will it reverse the cognitive deficits associated with anesthesia, after waking? The investigators carried out a modest trial with 8 test subjects. Each volunteer was anesthetized twice. Each volunteer was anesthetized one time and received an infusion of saline (placebo control), without the aid of any other drugs and the other time the volunteer received an infusion of a relatively low dose of caffeine. The order of saline versus caffeine was randomized and the study was done in a double blind manner. We observed that emergence from anesthesia was significantly accelerated by the caffeine infusion. No adverse events were observed.

Interventions

  • DRUG Caffeine
  • DRUG Placebo Control

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2016-08
Est. Completion 2017-05-01
Phase Phase 4

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT02567968

The ClinicalTrials.gov registry entry for NCT02567968 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Caffeine is the first listed.

NCT02567968 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02567968 about?

NCT02567968 is a clinical study titled "A Study to Determine if Caffeine Accelerates Emergence From Anesthesia". At present clinicians have no way to reverse anesthesia. Patients wake when their bodies clear the anesthetic. Most people wake quickly, but some do not. All patients have memory and other cognitive problems after waking from anesthesia. In studies on animals, the investigators observed that caffein...

What is the current status of trial NCT02567968?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2016-08. Estimated completion is 2017-05-01.

What interventions are being tested in trial NCT02567968?

The interventions under investigation include: Caffeine (DRUG), Placebo Control (DRUG).

Who is sponsoring clinical trial NCT02567968?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.